These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 8297652

  • 1. Deoxycytidine kinase and deoxycytidine deaminase activities in human tumour xenografts.
    Ruiz van Haperen VW, Veerman G, Braakhuis BJ, Vermorken JB, Boven E, Leyva A, Peters GJ.
    Eur J Cancer; 1993; 29A(15):2132-7. PubMed ID: 8297652
    [Abstract] [Full Text] [Related]

  • 2. Regulation of phosphorylation of deoxycytidine and 2',2'-difluorodeoxycytidine (gemcitabine); effects of cytidine 5'-triphosphate and uridine 5'-triphosphate in relation to chemosensitivity for 2',2'-difluorodeoxycytidine.
    van Haperen VW, Veerman G, Vermorken JB, Pinedo HM, Peters G.
    Biochem Pharmacol; 1996 Apr 12; 51(7):911-8. PubMed ID: 8651941
    [Abstract] [Full Text] [Related]

  • 3. Role of deoxycytidine kinase (dCK), thymidine kinase 2 (TK2), and deoxycytidine deaminase (dCDA) in the antitumor activity of gemcitabine (dFdC).
    Kroep JR, van Moorsel CJ, Veerman G, Voorn DA, Schultz RM, Worzalla JF, Tanzer LR, Merriman RL, Pinedo HM, Peters GJ.
    Adv Exp Med Biol; 1998 Apr 12; 431():657-60. PubMed ID: 9598147
    [No Abstract] [Full Text] [Related]

  • 4. Pretreatment deoxycytidine kinase levels predict in vivo gemcitabine sensitivity.
    Kroep JR, Loves WJ, van der Wilt CL, Alvarez E, Talianidis I, Boven E, Braakhuis BJ, van Groeningen CJ, Pinedo HM, Peters GJ.
    Mol Cancer Ther; 2002 Apr 12; 1(6):371-6. PubMed ID: 12477049
    [Abstract] [Full Text] [Related]

  • 5. Induction of resistance to 2',2'-difluorodeoxycytidine in the human ovarian cancer cell line A2780.
    Ruiz van Haperen VW, Veerman G, Eriksson S, Stegmann AP, Peters GJ.
    Semin Oncol; 1995 Aug 12; 22(4 Suppl 11):35-41. PubMed ID: 7481843
    [Abstract] [Full Text] [Related]

  • 6. Modifications of deoxycytidine kinase and deaminase activities by docosahexaenoic acid in normal and transformed rat fibroblasts.
    Cha MC, Meckling-Gill KA.
    Biochem Pharmacol; 2002 Feb 15; 63(4):717-23. PubMed ID: 11992640
    [Abstract] [Full Text] [Related]

  • 7. Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizer.
    Sigmond J, Honeywell RJ, Postma TJ, Dirven CM, de Lange SM, van der Born K, Laan AC, Baayen JC, Van Groeningen CJ, Bergman AM, Giaccone G, Peters GJ.
    Ann Oncol; 2009 Jan 15; 20(1):182-7. PubMed ID: 18701427
    [Abstract] [Full Text] [Related]

  • 8. Development and molecular characterization of a 2',2'-difluorodeoxycytidine-resistant variant of the human ovarian carcinoma cell line A2780.
    Ruiz van Haperen VW, Veerman G, Eriksson S, Boven E, Stegmann AP, Hermsen M, Vermorken JB, Pinedo HM, Peters GJ.
    Cancer Res; 1994 Aug 01; 54(15):4138-43. PubMed ID: 8033147
    [Abstract] [Full Text] [Related]

  • 9. Activation of deoxycytidine kinase by deoxyadenosine: implications in deoxyadenosine-mediated cytotoxicity.
    Keszler G, Virga S, Spasokoukotskaja T, Bauer PI, Sasvari-Szekely M, Staub M.
    Arch Biochem Biophys; 2005 Apr 01; 436(1):69-77. PubMed ID: 15752710
    [Abstract] [Full Text] [Related]

  • 10. In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant.
    Bergman AM, Eijk PP, Ruiz van Haperen VW, Smid K, Veerman G, Hubeek I, van den Ijssel P, Ylstra B, Peters GJ.
    Cancer Res; 2005 Oct 15; 65(20):9510-6. PubMed ID: 16230416
    [Abstract] [Full Text] [Related]

  • 11. Immunocytochemical detection of deoxycytidine kinase in haematological malignancies and solid tumours.
    Hubeek I, Peters GJ, Broekhuizen AJ, Talianidis I, Sigmond J, Gibson BE, Creutzig U, Giaccone G, Kaspers GJ.
    J Clin Pathol; 2005 Jul 15; 58(7):695-9. PubMed ID: 15976334
    [Abstract] [Full Text] [Related]

  • 12. Role of deoxycytidine kinase (dCK) activity in gemcitabine's radioenhancement in mice and human cell lines in vitro.
    Grégoire V, Rosier JF, De Bast M, Bruniaux M, De Coster B, Octave-Prignot M, Scalliet P.
    Radiother Oncol; 2002 Jun 15; 63(3):329-38. PubMed ID: 12142097
    [Abstract] [Full Text] [Related]

  • 13. Expression of deoxycytidine kinase in leukaemic cells compared with solid tumour cell lines, liver metastases and normal liver.
    van der Wilt CL, Kroep JR, Loves WJ, Rots MG, Van Groeningen CJ, Kaspers GJ, Peters GJ.
    Eur J Cancer; 2003 Mar 15; 39(5):691-7. PubMed ID: 12628850
    [Abstract] [Full Text] [Related]

  • 14. Impact of cytidine deaminase activity on intrinsic resistance to cytarabine in carcinoma cells.
    Ohta T, Hori H, Ogawa M, Miyahara M, Kawasaki H, Taniguchi N, Komada Y.
    Oncol Rep; 2004 Nov 15; 12(5):1115-20. PubMed ID: 15492802
    [Abstract] [Full Text] [Related]

  • 15. Tumor uptake and elimination of 2',2'-difluoro-2'-deoxycytidine (gemcitabine) after deoxycytidine kinase gene transfer: correlation with in vivo tumor response.
    Blackstock AW, Lightfoot H, Case LD, Tepper JE, Mukherji SK, Mitchell BS, Swarts SG, Hess SM.
    Clin Cancer Res; 2001 Oct 15; 7(10):3263-8. PubMed ID: 11595723
    [Abstract] [Full Text] [Related]

  • 16. Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity.
    Hapke DM, Stegmann AP, Mitchell BS.
    Cancer Res; 1996 May 15; 56(10):2343-7. PubMed ID: 8625309
    [Abstract] [Full Text] [Related]

  • 17. Changes in the activities of cytidine deaminase during differentiation of HL60 cells induced by 1,25 dihydroxy D3.
    Mejer J, Mortensen BT.
    Leuk Res; 1988 May 15; 12(5):405-9. PubMed ID: 3164086
    [Abstract] [Full Text] [Related]

  • 18. Profiles of pyrimidine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
    Katahira R, Ashihara H.
    Planta; 2002 Sep 15; 215(5):821-8. PubMed ID: 12244448
    [Abstract] [Full Text] [Related]

  • 19. Reduction of ara-C cytotoxicity in HL 60 cells by addition of deoxycytidine, cytidine or increased level of cytidine deaminase.
    Mejer J, Mortensen BT.
    Adv Exp Med Biol; 1989 Sep 15; 253B():335-9. PubMed ID: 2558539
    [No Abstract] [Full Text] [Related]

  • 20. Synergistic interaction between cisplatin and gemcitabine in ovarian and colon cancer cell lines.
    Bergman AM, Ruiz van Haperen VW, Veerman G, Kuiper CM, Peters GJ.
    Adv Exp Med Biol; 1994 Sep 15; 370():139-43. PubMed ID: 7660877
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.